Clazakizumab ELISA Kit
Selected Variant
DY328018
Size: 96 Tests
Product Specifications
Background
Clazakizumab, a humanized anti–IL-6 mAb, is used in the phase II clinical trial for the treatment of RA patients. It has also been evaluated for the treatment of non-small cell lung cancer (NSCLC) and patients with head and neck cancer.
Specifications
Clazakizumab
Product Name Alternative
ALD-518, BMS-945429, CAS: 1236278-28-6
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120%
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Notes
For Research Use Only.
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2569-100 1x 100 µL
GP2 (Glycoprotein 2) / ZAP75 (GP2/2569R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741996-100 1x 100 µL
HCG-beta (Pregnancy & Choriocarcinoma Marker) (HCGb/1996R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040838-100 1x 100 µL
MAGE A1 (MZ2E/838), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC050506-500 1x 500 µL
Estrogen Receptor (ER506), CF405M conjugate, 0.1mg/mL
Sign In for Pricing
View Details 